A $100 million international project to sequence the bovine genome is being launched following an intensive lobbying effort in which CSIRO played a key role.

Pooled development fund Medica Holdings has completed a fund-raising trifecta for its stable of biotech investee companies.

Materials science start-up Polymerat has glimpsed light at the end of the tunnel by signing its first joint product development agreements with established biotechs.

Brisbane start-up company Thrombostat has attracted AUD$800,000 in venture capital and grants to develop drugs that could displace aspirin in long-term prevention and treatment of cardiovascular disease.

Two of the leading forces in Australian bioinformatics are pooling their expertise to build a new generation of protein expression data mining tools.

Ethics committees helping to oversee bio-research need to be put on a more professional footing, according a leading member of Australia’s ethics community, Prof Wayne Hall.

The funding floodgates suddenly appear to have swung open for young and not-so-young biotechs -- at least in Queensland.

Brisbane firm Alchemia has capped a lengthy hunt for additional investment by securing $2.75 million in fresh funding, according to CEO Tracie Ramsdale.

Web portal use by the research community and the popularity of grid computing are two leading trends in today's bioIT market, according to Sun Microsystems computational biology supremo Stefan Unger.

A $54 million Cooperative Research Centre using biotech to inject fresh life into the economics of the sugar industry is due to open for business next month.

Victoria trails Queensland among state governments which are energetically supporting bioscience and needs to fine-tune its Bio 21 initiative, according to one of the bioIT industry's most unusual executives, Michael Armitage.